{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:23:39Z","timestamp":1790616219527,"version":"4.1.0"},"reference-count":154,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["EEQ\/2016\/000758"],"award-info":[{"award-number":["EEQ\/2016\/000758"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.phrs.2021.105618","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:31:51Z","timestamp":1618792311000},"page":"105618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends"],"prefix":"10.1016","volume":"169","author":[{"given":"Gurleen","family":"Kour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Assim","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijender Kumar","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prem N.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabeer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res."},{"key":"10.1016\/j.phrs.2021.105618_bib2","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"issue":"42","key":"10.1016\/j.phrs.2021.105618_bib3","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1136\/annrheumdis-2014-206785","article-title":"Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis","volume":"75","author":"Juarez","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"23","key":"10.1016\/j.phrs.2021.105618_bib5","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast\u2010like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1010","article-title":"Roles of B cells in rheumatoid arthritis","volume":"5","author":"Silverman","year":"2003","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.0060001","article-title":"Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium","volume":"6","author":"Humby","year":"2009","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.phrs.2021.105618_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.7326\/0003-4819-148-2-200801150-00192","article-title":"Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis","volume":"148","author":"Donahue","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00002281-200205000-00002","article-title":"Tumor necrosis factor-\u03b1 antagonists for the treatment of rheumatic diseases","volume":"14","author":"Criscione","year":"2002","journal-title":"Curr. Opin. Rheumatol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105618_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nrd.2017.201","article-title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","volume":"16","author":"Schwartz","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib12","first-page":"vi28","article-title":"Evolution of treatment for rheumatoid arthritis","volume":"51","author":"Upchurch","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2021.105618_bib13","first-page":"1","article-title":"Reflections on \u2018older\u2019drugs: learning new lessons in rheumatology","author":"Kerrigan","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105618_bib14","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s12026-014-8564-6","article-title":"Three decades of low-dose methotrexate in rheumatoid arthritis: can we predict toxicity?","volume":"60","author":"Romao","year":"2014","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib15","first-page":"197","article-title":"Folate supplementation for methotrexate therapy in patients with rheumatoid arthritis: a systematic review","volume":"25","author":"Liu","year":"2019","journal-title":"JCR: J. Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib16","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib18","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/rheumatology\/keh500","article-title":"Leflunomide in rheumatoid arthritis: recommendations through a process of consensus","volume":"44","author":"Maddison","year":"2005","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.phrs.2021.105618_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41584-019-0240-8","article-title":"Stratifying management of rheumatic disease for pregnancy and breastfeeding","volume":"15","author":"Giles","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib20","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American college of rheumatology 2008 recommendations for the use of nonbiologic and biologic disease\u2010modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Care Res.: Off. J. Am. Coll. Rheumatol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105618_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1517\/14740338.2011.529898","article-title":"Oxidative stress as a mechanism underlying sulfasalazine-induced toxicity","volume":"10","author":"Linares","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"issue":"11","key":"10.1016\/j.phrs.2021.105618_bib22","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3899\/jrheum.170158","article-title":"Risk of retinal toxicity in longterm users of hydroxychloroquine","volume":"44","author":"Kim","year":"2017","journal-title":"J. Rheumatol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105618_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/jamaophthalmol.2014.3459","article-title":"The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"JAMA Ophthalmol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105618_bib24","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site\u2010specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti\u2013tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib25","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib26","first-page":"vi37","article-title":"Overview of safety of non-biologic and biologic DMARDs","volume":"51","author":"Ruderman","year":"2012","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.phrs.2021.105618_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2009.146","article-title":"Risk of herpes zoster in patients with rheumatoid arthritis treated with anti\u2013TNF-\u03b1 agents","volume":"301","author":"Strangfeld","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.phrs.2021.105618_bib28","series-title":"Seminars in Arthritis and Rheumatism","first-page":"208","article-title":"Use of tumor necrosis factor-\u03b1 inhibitors in patients with chronic hepatitis B infection","author":"Carroll","year":"2008"},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-59406-4","article-title":"Moderate risk of Hepatitis B virus reactivation in HBsAg\u2212\/HBcAb+ carriers receiving rituximab for rheumatoid arthritis","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2021.105618_bib30","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/annrheumdis-2016-210457","article-title":"Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials","volume":"76","author":"Cohen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib31","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40259-018-0304-3","article-title":"Risk of adverse drug events observed with baricitinib 2 mg versus baricitinib 4 mg once daily for the treatment of rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"32","author":"Huang","year":"2018","journal-title":"BioDrugs"},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrrheum.2013.197","article-title":"The safety of biologic therapies in RA-associated interstitial lung disease","volume":"10","author":"Jani","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105618_bib33","series-title":"Phytochemicals as Lead Compounds for New Drug Discovery","first-page":"3","article-title":"Plant secondary metabolites as lead compounds for the production of potent drugs","author":"Srivastav","year":"2020"},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib34","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/molecules18010322","article-title":"Molecular mechanism underlying anti-inflammatory and anti-allergic activities of phytochemicals: an update","volume":"18","author":"Bellik","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2021.105618_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pharmthera.2018.09.009","article-title":"The role of flavonoids in autoimmune diseases: therapeutic updates","volume":"194","author":"Rengasamy","year":"2019","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2021.105618_bib36","series-title":"Studies in Natural Products Chemistry","first-page":"65","article-title":"The antiinflammatory potential of flavonoids: mechanistic aspects","author":"Catarino","year":"2016"},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1017\/S002966511000162X","article-title":"Flavonoids as anti-inflammatory agents","volume":"69","author":"Serafini","year":"2010","journal-title":"Proc. Nutr. Soc."},{"issue":"17","key":"10.1016\/j.phrs.2021.105618_bib38","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1080\/10408398.2016.1246413","article-title":"The therapeutic potential of plant flavonoids on rheumatoid arthritis","volume":"57","author":"Hughes","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"10","key":"10.1016\/j.phrs.2021.105618_bib39","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/annrheumdis-2018-213289","article-title":"Inequity in access to bDMARD care and how it influences disease outcomes across countries worldwide: results from the METEOR-registry","volume":"77","author":"Bergstra","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2021.105618_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","author":"Smolen","year":"2020","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/nu9010045","article-title":"Resveratrol, potential therapeutic interest in joint disorders: a critical narrative review","volume":"9","author":"Nguyen","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/abbs\/gmu135","article-title":"Anti-inflammatory effect of resveratrol through the suppression of NF-\u03baB and JAK\/STAT signaling pathways","volume":"47","author":"Ma","year":"2015","journal-title":"Acta Biochim. Et Biophys. Sin."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/ard.2011.149831","article-title":"Resveratrol modulates murine collagen-induced arthritis by inhibiting Th17 and B-cell function","volume":"71","author":"Xuzhu","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2021.105618_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.taap.2016.06.030","article-title":"P-gp, MRP2 and OAT1\/OAT3 mediate the drug-drug interaction between resveratrol and methotrexate","volume":"306","author":"Jia","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-018-0036-5","article-title":"Resveratrol displays anti-inflammatory properties in an ex vivo model of immune mediated inflammatory arthritis","volume":"2","author":"Lomholt","year":"2018","journal-title":"BMC Rheumatol."},{"key":"10.1016\/j.phrs.2021.105618_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.abb.2015.08.008","article-title":"Quercetin reduced inflammation and increased antioxidant defense in rat adjuvant arthritis","volume":"583","author":"Gardi","year":"2015","journal-title":"Arch. Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib47","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1007\/s10753-012-9473-2","article-title":"Quercetin inhibits IL-1\u03b2-induced proliferation and production of MMPs, COX-2, and PGE2 by rheumatoid synovial fibroblast","volume":"35","author":"Sung","year":"2012","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s10787-018-0464-2","article-title":"Flavonoid quercetin\u2013methotrexate combination inhibits inflammatory mediators and matrix metalloproteinase expression, providing protection to joints in collagen-induced arthritis","volume":"26","author":"Sun","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.phrs.2021.105618_bib49","doi-asserted-by":"crossref","DOI":"10.29219\/fnr.v62.1327","article-title":"Quercetin prevents small intestinal damage and enhances intestinal recovery during methotrexate-induced intestinal mucositis of rats","volume":"62","author":"Sukhotnik","year":"2018","journal-title":"Food Nutr. Res."},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib50","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.intimp.2007.01.007","article-title":"Sinomenine inhibits maturation of monocyte-derived dendritic cells through blocking activation of NF-kappa B","volume":"7","author":"Zhao","year":"2007","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jep.2011.05.048","article-title":"Anti-inflammatory activities of Chinese herbal medicine sinomenine and Liang Miao San on tumor necrosis factor-\u03b1-activated human fibroblast-like synoviocytes in rheumatoid arthritis","volume":"137","author":"Chen","year":"2011","journal-title":"J. Ethnopharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib52","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0254-6272(16)30075-9","article-title":"Effects and safety of Sinomenine in treatment of rheumatoid arthritis contrast to methotrexate: a systematic review and Meta-analysis","volume":"36","author":"Weiwei","year":"2016","journal-title":"J. Tradit. Chin. Med."},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib53","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1007\/s10753-013-9648-5","article-title":"Sinomenine decreases MyD88 expression and improves inflammation-induced joint damage progression and symptoms in rat adjuvant-induced arthritis","volume":"36","author":"Mu","year":"2013","journal-title":"Inflammation"},{"issue":"15","key":"10.1016\/j.phrs.2021.105618_bib54","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1055\/s-2006-951721","article-title":"Suppression of Th1 and Th2 immune responses in mice by Sinomenine, an alkaloid extracted from the chinese medicinal plant Sinomenium acutum","volume":"72","author":"Feng","year":"2006","journal-title":"Planta Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib55","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.intimp.2013.11.014","article-title":"A combination of sinomenine and methotrexate reduces joint damage of collagen induced arthritis in rats by modulating osteoclast-related cytokines","volume":"18","author":"Roy","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ypmed.2009.05.005","article-title":"Can green tea do that? A literature review of the clinical evidence","volume":"49","author":"Clement","year":"2009","journal-title":"Prev. Med."},{"issue":"12","key":"10.1016\/j.phrs.2021.105618_bib57","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.bcp.2011.07.093","article-title":"Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications","volume":"82","author":"Singh","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127165","article-title":"Intra-articular injections of polyphenols protect articular cartilage from inflammation-induced degradation: suggesting a potential role in cartilage therapeutics","volume":"10","author":"Natarajan","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.phrs.2021.105618_bib59","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0891-5849(02)01004-3","article-title":"Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1\u03b2-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes","volume":"33","author":"Ahmed","year":"2002","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/ar3368","article-title":"Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes","volume":"13","author":"Akhtar","year":"2011","journal-title":"Arthritis Res. Ther."},{"issue":"1\u20133","key":"10.1016\/j.phrs.2021.105618_bib61","first-page":"444","article-title":"Combination therapy of dexamethasone with epigallocatechin enhances tibiotarsal bone articulation and modulates oxidative status correlates with cartilage cytokines expression in the early phase of experimental arthritis","volume":"698","author":"Banji","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib62","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s10753-012-9457-2","article-title":"A novel combination of methotrexate and epigallocatechin attenuates the overexpression of pro-inflammatory cartilage cytokines and modulates antioxidant status in adjuvant arthritic rats","volume":"35","author":"Roy","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.phrs.2021.105618_bib63","first-page":"4931","article-title":"The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats","volume":"9","author":"Zheng","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phrs.2021.105618_bib64","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.2147\/DDDT.S175763","article-title":"Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats","volume":"12","author":"Dai","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"issue":"11","key":"10.1016\/j.phrs.2021.105618_bib65","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/ptr.4639","article-title":"A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis","volume":"26","author":"Chandran","year":"2012","journal-title":"Phytother. Res."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105618_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejphar.2011.06.006","article-title":"Synergistic activity of curcumin with methotrexate in ameliorating Freund\u2019s Complete Adjuvant induced arthritis with reduced hepatotoxicity in experimental animals","volume":"668","author":"Banji","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/biof.5520310104","article-title":"Effects of Coenzyme Q_ {10} on TNF-\u03b1 secretion in human and murine monocytic cell lines","volume":"31","author":"Schmelzer","year":"2007","journal-title":"Biofactors"},{"issue":"1\u20134","key":"10.1016\/j.phrs.2021.105618_bib68","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/biof.5520320121","article-title":"Functions of coenzyme Q10 in inflammation and gene expression","volume":"32","author":"Schmelzer","year":"2008","journal-title":"Biofactors"},{"issue":"7","key":"10.1016\/j.phrs.2021.105618_bib69","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.arcmed.2015.08.006","article-title":"Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-\u03b1, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial","volume":"46","author":"Abdollahzad","year":"2015","journal-title":"Arch. Med. Res."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib70","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.intimp.2014.11.018","article-title":"Combination of coenzyme Q10 with methotrexate suppresses Freund\u2019s complete adjuvant-induced synovial inflammation with reduced hepatotoxicity in rats: effect on oxidative stress and inflammation","volume":"24","author":"Tawfik","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2021.105618_bib71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3945\/jn.108.097386","article-title":"Ferulaldehyde, a water-soluble degradation product of polyphenols, inhibits the lipopolysaccharide-induced inflammatory response in mice","volume":"139","author":"Radnai","year":"2009","journal-title":"J. Nutr."},{"issue":"11","key":"10.1016\/j.phrs.2021.105618_bib72","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3390\/molecules22111911","article-title":"Ferulaldehyde improves the effect of methotrexate in experimental arthritis","volume":"22","author":"Slov\u00e1k","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S0007114509991486","article-title":"Protective effect of serotonin derivatives on glucose-induced damage in PC12 rat pheochromocytoma cells","volume":"103","author":"Piga","year":"2010","journal-title":"Br. J. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2021.105618_bib74","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1017\/S0007114508201947","article-title":"Inhibitory effect of serotonin derivatives on high glucose-induced adhesion and migration of monocytes on human aortic endothelial cells","volume":"102","author":"Piga","year":"2009","journal-title":"Br. J. Nutr."},{"issue":"14","key":"10.1016\/j.phrs.2021.105618_bib75","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1021\/jf060254p","article-title":"Serotonin derivatives, major safflower (Carthamus tinctorius L.) seed antioxidants, inhibit low-density lipoprotein (LDL) oxidation and atherosclerosis in apolipoprotein E-deficient mice","volume":"54","author":"Koyama","year":"2006","journal-title":"J. Agric. Food Chem."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib76","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/fcp.12085","article-title":"N\u2010feruloylserotonin in preventive combination therapy with methotrexate reduced inflammation in adjuvant arthritis","volume":"28","author":"Kuncirova","year":"2014","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib77","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7509653","article-title":"Effect of N-feruloylserotonin and methotrexate on severity of experimental arthritis and on messenger RNA expression of key proinflammatory markers in liver","volume":"2016","author":"Pa\u0161kov\u00e1","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.phrs.2021.105618_bib78","unstructured":"K. Visser, D. Van der Heijde, Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature, Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet], Centre for Reviews and Dissemination (UK) 2009."},{"issue":"2","key":"10.1016\/j.phrs.2021.105618_bib79","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/1568026613666131213155252","article-title":"Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea","volume":"14","author":"Derosa","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105618_bib80","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","article-title":"The metabolism of berberine and its contribution to the pharmacological effects","volume":"49","author":"Wang","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.phrs.2021.105618_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biopha.2017.10.113","article-title":"Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats","volume":"97","author":"Mehrzadi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.phrs.2021.105618_bib82","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/antiox8120571","article-title":"Andrographolide, a natural antioxidant: an update","volume":"8","author":"Mussard","year":"2019","journal-title":"Antioxidants"},{"key":"10.1016\/j.phrs.2021.105618_bib83","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jep.2014.10.056","article-title":"Modulation of thioacetamide-induced hepatic inflammations, angiogenesis and fibrosis by andrographolide in mice","volume":"158","author":"Lee","year":"2014","journal-title":"J. Ethnopharmacol."},{"issue":"25","key":"10.1016\/j.phrs.2021.105618_bib84","doi-asserted-by":"crossref","first-page":"41202","DOI":"10.18632\/oncotarget.17149","article-title":"Andrographolide ameliorates d-galactosamine\/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway","volume":"8","author":"Pan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2021.105618_bib85","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.biopha.2018.07.001","article-title":"Evaluation of the effect of andrographolide and methotrexate combined therapy in complete Freund\u02bcs adjuvant induced arthritis with reduced hepatotoxicity","volume":"106","author":"Li","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105618_bib86","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ijbiomac.2019.03.188","article-title":"Inulin: a novel and stretchy polysaccharide tool for biomedical and nutritional applications","volume":"132","author":"Gupta","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2021.105618_bib87","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.ijbiomac.2014.09.066","article-title":"Antioxidant and protective effect of inulin and catechin grafted inulin against CCl4-induced liver injury","volume":"72","author":"Liu","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.phrs.2021.105618_bib88","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.biopha.2018.11.144","article-title":"Protective effect of inulin on methotrexate-induced liver toxicity in mice","volume":"110","author":"Kalantari","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib89","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s10753-015-0140-2","article-title":"Anti-inflammatory activity of magnesium isoglycyrrhizinate through inhibition of phospholipase A2\/arachidonic acid pathway","volume":"38","author":"Xie","year":"2015","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib90","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/09540105.2019.1571565","article-title":"Liver-protecting effects of extracts from Glossy privet fruit and Ecliptae herba formula in mice through suppression of Kupffer cells activation","volume":"30","author":"Zhao","year":"2019","journal-title":"Food Agric. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib91","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/10717544.2018.1472676","article-title":"Licorice root extract and magnesium isoglycyrrhizinate protect against triptolide-induced hepatotoxicity via up-regulation of the Nrf2 pathway","volume":"25","author":"Tan","year":"2018","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib92","first-page":"2020","article-title":"Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin\u2011induced model of liver injury","volume":"42","author":"Zou","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2021.105618_bib93","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fphar.2019.00119","article-title":"Protective effects of magnesium glycyrrhizinate on methotrexate-induced hepatotoxicity and intestinal toxicity may be by reducing COX-2","volume":"10","author":"Bu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib94","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fphar.2016.00247","article-title":"A comprehensive and system review for the pharmacological mechanism of action of rhein, an active anthraquinone ingredient","volume":"7","author":"Sun","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib95","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.freeradbiomed.2017.11.021","article-title":"Diacerein alleviates kidney injury through attenuating inflammation and oxidative stress in obese insulin-resistant rats","volume":"115","author":"Chueakula","year":"2018","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2021.105618_bib96","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2147\/DDDT.S133069","article-title":"Rhein attenuates inflammation through inhibition of NF-\u03baB and NALP3 inflammasome in vivo and in vitro","volume":"11","author":"Ge","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.phrs.2021.105618_bib97","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejphar.2018.07.031","article-title":"Hepatoprotective effect of rhein against methotrexate-induced liver toxicity","volume":"834","author":"Bu","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib98","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopha.2017.10.064","article-title":"Chlorogenic acid (CGA): a pharmacological review and call for further research","volume":"97","author":"Naveed","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib99","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00011-013-0674-4","article-title":"Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells","volume":"63","author":"Hwang","year":"2014","journal-title":"Inflamm. Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib100","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.clnu.2016.03.002","article-title":"Chlorogenic acid protects against liver fibrosis in vivo and in vitro through inhibition of oxidative stress","volume":"35","author":"Shi","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.phrs.2021.105618_bib101","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cbi.2017.05.002","article-title":"Protective effect of Chlorogenic acid against methotrexate induced oxidative stress, inflammation and apoptosis in rat liver: an experimental approach","volume":"272","author":"Ali","year":"2017","journal-title":"Chem. -Biol. Interact."},{"issue":"7","key":"10.1016\/j.phrs.2021.105618_bib102","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00393-011-0830-6","article-title":"Is methotrexate nephrotoxic? Dose-dependency, comorbidities and comedication","volume":"70","author":"Erdbr\u00fcgger","year":"2011","journal-title":"Z. Fur Rheumatol."},{"issue":"11","key":"10.1016\/j.phrs.2021.105618_bib103","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/014107680409701106","article-title":"Methotrexate toxicity induced by acute renal failure","volume":"97","author":"Strang","year":"2004","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.phrs.2021.105618_bib104","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00296-020-04547-y","article-title":"Methotrexate-related toxicity in patients with rheumatoid arthritis and renal dysfunction","volume":"40","author":"Lee","year":"2020","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2021.105618_bib105","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","article-title":"Quercetin: a flavonol with multifaceted therapeutic applications?","volume":"106","author":"D\u2019Andrea","year":"2015","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib106","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3390\/ijms15010484","article-title":"The inhibitory effect of quercetin on asymmetric dimethylarginine-induced apoptosis is mediated by the endoplasmic reticulum stress pathway in glomerular endothelial cells","volume":"15","author":"Guo","year":"2014","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib107","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00709-014-0670-8","article-title":"Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid","volume":"252","author":"Chaudhary","year":"2015","journal-title":"Protoplasma"},{"issue":"9","key":"10.1016\/j.phrs.2021.105618_bib108","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.3109\/0886022X.2015.1074521","article-title":"Quercetin ameliorates methotrexate-induced renal damage, apoptosis and oxidative stress in rats","volume":"37","author":"Erboga","year":"2015","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib109","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000491755","article-title":"Antioxidant properties of ferulic acid and its possible application","volume":"31","author":"Zdu\u0144ska","year":"2018","journal-title":"Skin Pharmacol. Physiol."},{"key":"10.1016\/j.phrs.2021.105618_bib110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.biopha.2018.01.169","article-title":"Ferulic acid protects lipopolysaccharide-induced acute kidney injury by suppressing inflammatory events and upregulating antioxidant defenses in Balb\/c mice","volume":"100","author":"Mir","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105618_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fphar.2019.00027","article-title":"Ferulic acid protects hyperglycemia-induced kidney damage by regulating oxidative insult, inflammation and autophagy","volume":"10","author":"Chowdhury","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105618_bib112","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1039\/C9FO00114J","article-title":"Ferulic acid protects against methotrexate nephrotoxicity via activation of Nrf2\/ARE\/HO-1 signaling and PPAR\u03b3, and suppression of NF-\u03baB\/NLRP3 inflammasome axis","volume":"10","author":"Mahmoud","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2021.105618_bib113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/803971","article-title":"An organ system approach to explore the antioxidative, anti-inflammatory, and cytoprotective actions of resveratrol","volume":"2015","author":"Malhotra","year":"2015","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.phrs.2021.105618_bib114","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.biopha.2018.11.075","article-title":"Resveratrol: from enhanced biosynthesis and bioavailability to multitargeting chronic diseases","volume":"109","author":"Pannu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.phrs.2021.105618_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/568093","article-title":"Renal protective effects of resveratrol","volume":"2013","author":"Kitada","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib116","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12935-014-0152-2","article-title":"Chemosensitizing and nephroprotective effect of resveratrol in cisplatin\u2013treated animals","volume":"15","author":"Osman","year":"2015","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.phrs.2021.105618_bib117","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/fcp.12205","article-title":"Protective mechanisms of resveratrol against methotrexate\u2010induced renal damage may involve BCRP\/ABCG2","volume":"30","author":"El\u2010Sheikh","year":"2016","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118642","article-title":"Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: an overview","volume":"570","author":"Zhao","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.phrs.2021.105618_bib119","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jconrel.2016.09.017","article-title":"Recent expansion of pharmaceutical nanotechnologies and targeting strategies in the field of phytopharmaceuticals for the delivery of herbal extracts and bioactives","volume":"241","author":"Alexander","year":"2016","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.eng.2018.12.004","article-title":"Andrographolide loaded in micro-and Nano-formulations: improved bioavailability, target-tissue distribution, and efficacy of the king of bitters","volume":"5","author":"Casamonti","year":"2019","journal-title":"Engineering"},{"issue":"73","key":"10.1016\/j.phrs.2021.105618_bib121","doi-asserted-by":"crossref","first-page":"69282","DOI":"10.1039\/C6RA12161F","article-title":"Strategies for formulation development of andrographolide","volume":"6","author":"Pawar","year":"2016","journal-title":"RSC Adv."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2021.105618_bib122","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ijpharm.2014.09.016","article-title":"Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro\u2013in vivo correlation","volume":"475","author":"Jiang","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.phrs.2021.105618_bib123","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.3390\/ijms21072506","article-title":"Oral bioavailability enhancement and anti-fatigue assessment of the andrographolide loaded solid dispersion","volume":"21","author":"Yen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2021.105618_bib124","first-page":"4723","article-title":"Engineered andrographolide nanosystems for smart recovery in hepatotoxic conditions","volume":"9","author":"Roy","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2021.105618_bib125","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cbi.2015.10.011","article-title":"Enhanced protective activity of nano formulated andrographolide against arsenic induced liver damage","volume":"242","author":"Das","year":"2015","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.phrs.2021.105618_bib126","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2147\/IJN.S154824","article-title":"Nanoemulsion as a strategy for improving the oral bioavailability and anti-inflammatory activity of andrographolide","volume":"13","author":"Yen","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.phrs.2021.105618_bib127","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.2147\/IJN.S164228","article-title":"Novel nanocrystal-based solid dispersion with high drug loading, enhanced dissolution, and bioavailability of andrographolide","volume":"13","author":"Ma","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib128","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/jps.22266","article-title":"Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis","volume":"100","author":"Natarajan","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.phrs.2021.105618_bib129","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108622","article-title":"Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: In vivo and in vitro studies","volume":"112","author":"Gokhale","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib130","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s11095-013-1213-2","article-title":"Solidified self-nanoemulsifying formulation for oral delivery of combinatorial therapeutic regimen: part I. Formulation development, statistical optimization, and in vitro characterization","volume":"31","author":"Jain","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.phrs.2021.105618_bib131","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.2147\/IJN.S188842","article-title":"Enhanced transdermal permeability and drug deposition of rheumatoid arthritis via sinomenine hydrochloride-loaded antioxidant surface transethosome","volume":"14","author":"Song","year":"2019","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib132","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1080\/10717544.2020.1754524","article-title":"Polyvinylpyrrolidone microneedles for localized delivery of sinomenine hydrochloride: preparation, release behavior of in vitro & in vivo, and penetration mechanism","volume":"27","author":"Shu","year":"2020","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2021.105618_bib133","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.2147\/IJN.S164235","article-title":"Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity","volume":"13","author":"Siu","year":"2018","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.phrs.2021.105618_bib134","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3109\/10717544.2014.924167","article-title":"Preparation and in vitro\/in vivo evaluation of resveratrol-loaded carboxymethyl chitosan nanoparticles","volume":"23","author":"Zu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2021.105618_bib135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12247-019-09406-3","article-title":"Combination and co-delivery of methotrexate and curcumin: preparation and in vitro cytotoxic investigation on glioma cells","volume":"15","author":"Mujokoro","year":"2019","journal-title":"J. Pharm. Innov."},{"issue":"8","key":"10.1016\/j.phrs.2021.105618_bib136","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s10067-018-4080-8","article-title":"Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study","volume":"37","author":"Khojah","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105618_bib137","first-page":"1","article-title":"Systemic review and meta-analysis of the clinical efficacy and adverse effects of zhengqing fengtongning combined with methotrexate in rheumatoid arthritis","volume":"2015","author":"Chen","year":"2015","journal-title":"Evid. -Based Complement. Altern. Med."},{"key":"10.1016\/j.phrs.2021.105618_bib138","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.phymed.2018.12.030","article-title":"Comparison of combination therapy with methotrexate and sinomenine or leflunomide for active rheumatoid arthritis: a randomized controlled clinical trial","volume":"57","author":"Huang","year":"2019","journal-title":"Phytomedicine"},{"issue":"12","key":"10.1016\/j.phrs.2021.105618_bib139","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1007\/s10067-019-04723-x","article-title":"Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial","volume":"38","author":"Nachvak","year":"2019","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"10.1016\/j.phrs.2021.105618_bib140","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00296-011-1841-y","article-title":"A Chinese herb Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: mechanism, efficacy, and safety","volume":"31","author":"Bao","year":"2011","journal-title":"Rheumatol. Int."},{"issue":"8","key":"10.1016\/j.phrs.2021.105618_bib141","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.phytochem.2007.02.021","article-title":"Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii","volume":"68","author":"Ma","year":"2007","journal-title":"Phytochemistry"},{"key":"10.1016\/j.phrs.2021.105618_bib142","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.fitote.2015.06.003","article-title":"Anti-inflammatory sesquiterpene pyridine alkaloids from Tripterygium wilfordii","volume":"105","author":"Gao","year":"2015","journal-title":"Fitoterapia"},{"key":"10.1016\/j.phrs.2021.105618_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103288","article-title":"Dihydro-\u03b2-agarofuran sesquiterpenoid derivatives with anti-inflammatory activity from the leaves of Tripterygium wilfordii","volume":"92","author":"He","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.phrs.2021.105618_bib144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/9148523","article-title":"Tripterygium wilfordii glycosides upregulate the new anti-inflammatory cytokine IL-37 through ERK1\/2 and p38 MAPK signal pathways","volume":"2017","author":"Wang","year":"2017","journal-title":"Evid. -Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12906-016-1194-x","article-title":"Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"issue":"4","key":"10.1016\/j.phrs.2021.105618_bib146","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-151-4-200908180-00005","article-title":"Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial","volume":"151","author":"Goldbach-Mansky","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.105618_bib147","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/annrheumdis-2013-204807","article-title":"Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial","volume":"74","author":"Lv","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2021.105618_bib148","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.lfs.2017.01.004","article-title":"Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: a meta-analysis","volume":"171","author":"Wang","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2021.105618_bib149","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2011.00010","article-title":"Anti-inflammatory and immunomodulatory effects of Paeonia lactiflora Pall., a traditional Chinese herbal medicine","volume":"2","author":"He","year":"2011","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2021.105618_bib150","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5114\/aoms.2011.24129","article-title":"Protective effects of total glucosides of paeony and the underlying mechanisms in carbon tetrachloride-induced experimental liver injury","author":"Qin","year":"2011","journal-title":"Arch. Med. Sci.: AMS"},{"key":"10.1016\/j.phrs.2021.105618_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107452","article-title":"Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony","volume":"207","author":"Zhang","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib152","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.intimp.2015.08.008","article-title":"Total glucosides of paeony can reduce the hepatotoxicity caused by Methotrexate and Leflunomide combination treatment of active rheumatoid arthritis","volume":"28","author":"Xiang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105618_bib153","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10067-017-3770-y","article-title":"A systemic review and meta-analysis of the clinical efficacy and safety of total glucosides of peony combined with methotrexate in rheumatoid arthritis","volume":"37","author":"Feng","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2021.105618_bib154","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2147\/DDDT.S207226","article-title":"Efficacy and safety of total glucosides of paeony combined with methotrexate and leflunomide for active rheumatoid arthritis: a meta-analysis","volume":"13","author":"Huang","year":"2019","journal-title":"Drug Des. Dev. Ther."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821002024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821002024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:23:43Z","timestamp":1760912623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821002024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":154,"alternative-id":["S1043661821002024"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105618","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phytochemical add-on therapy to DMARDs therapy in rheumatoid arthritis: In vitro and in vivo bases, clinical evidence and future trends","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105618","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105618"}}